GlassScriptPhysician profile
William S Kubricht
NPI 1477550705
$3,994.89
in general payments reported to CMS, 2019-2025
38 companies · $350 in 2025
The $350 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $282 · 2021: $678 · 2022: $523 · 2023: $743 · 2024: $895 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,902 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,902.20 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $816.39 | 2019-2024 | Xtandi, Myrbetriq, Veozah |
| Abbvie INC. | $493.39 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $380.59 | 2023-2025 | Gemtesa, Orgovyx |
| Merz North America, INC. | $313.69 | 2019-2022 | |
| Allergan, INC. | $259.38 | 2019-2022 | |
| Femselect INC. | $230.00 | 2023 | Enplace |
| Caldera Medical, INC | $213.65 | 2024 | Desara |
| Procept Biorobotics Corporation | $191.70 | 2021-2025 | Aquabeam Robotic System, Aquabeam System |
| Janssen Biotech, INC. | $163.05 | 2019-2022 | |
| Antares Pharma, INC. | $99.72 | 2019-2024 | Xyosted |
| Dendreon Pharmaceuticals LLC | $82.23 | 2019-2024 | Provenge |
| Urovant Sciences INC | $71.17 | 2021-2022 | |
| Stryker Corporation | $66.90 | 2023 | Fluid Management System |
| Blue Earth Diagnostics | $41.18 | 2019-2022 | |
| Urogen Pharma, INC. | $37.87 | 2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $37.70 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $37.34 | 2022 | |
| Boston Scientific Corporation | $36.09 | 2024 | Solyx Sis System |
| Halozyme INC | $32.41 | 2023 | |
| Mission Pharmacal Company | $31.62 | 2022-2024 | Uribel Tabs |
| Therapeuticsmd, INC. | $29.93 | 2021-2022 | |
| Pfizer INC. | $28.91 | 2019-2022 | |
| Neotract INC. | $26.52 | 2019 | |
| Novartis Pharmaceuticals Corporation | $26.48 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.11 | 2019 | |
| Civco Medical Instruments | $22.85 | 2024 | |
| Myriad Genetic Laboratories, INC. | $22.85 | 2024 | Prolaris |
| Agiliti Surgical, INC. | $19.65 | 2019 | |
| Tolmar, INC. | $18.47 | 2023 | |
| Dornier Medtech America, INC | $17.84 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.15 | 2024 | Adstiladrin |
| Tolmar Pharmaceuticals, INC. | $16.49 | 2019 | |
| Axonics, INC. | $16.16 | 2022 | |
| Verity Pharmaceuticals INC. | $15.98 | 2024 | Trelstar |
| Coloplast Corp | $15.72 | 2024 | |
| Accord Healthcare, INC. | $15.47 | 2023 | |
| Clarus Therapeutics INC. | $12.42 | 2021 | |
| Ethicon US, LLC | $11.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Kubricht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.